What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

AIQ Solutions

Home
United States
Madison, WI
AIQ Solutions

Novel software medical device for managing late-stage cancer. Oncology clinical decision support SaaS

10/20/2023

Join AIQ Solutions on Sunday for our poster presentations at .

10/17/2023

AIQ Co-Founder and CSO will be speaking about AI-Based Quantitative Imaging Biomarkers at the Prostate Cancer Foundation Retreat.

10/16/2023

Click on the link to register today for our upcoming panel discussion with ESSA Pharma and Xcovery: https://shorturl.at/pqAM0

10/12/2023

AIQ is pleased to announce acceptance for publication of their manuscript on deep learning-based organ segmentation models which demonstrates robust performance across a variety of CT scanner manufacturers and models. Click to read more: https://iopscience.iop.org/article/10.1088/2057-1976/acfb06/meta

10/10/2023

In light of October being Breast Cancer Awareness Month, we'd like to highlight the collaboration between AIQ and GE HealthCare. Their PET/CT tracer, Cerianna, reveals whole-body ER+ lesion status in patients with recurrent or metastatic breast cancer. Click here to see the abstract presented at https://www.aiq-services.com/wp-content/uploads/2023/09/Automated-Lesion-Detection-for-18F-Fluoroestradiol-PETCT-Images.pdf

10/03/2023

Molecular Imaging is used beyond diagnostics but also for therapy selection and optimization. AIQ is thrilled to join the peers from the Society of Nuclear Medicine and Molecular ImagingSNMMI to bring forth more information from the images. Celebrate to raise awareness of how nuclear medicine and molecular imaging are saving lives.

10/02/2023

Eric will be presenting AIQ Solutions at the MedInvest Medtech, AI, and Digital Health Conference this week.

09/26/2023

The National Cancer Institute (NCI) has awarded AIQ a $2M SBIR grant to develop predictive algorithms for both treatment effectiveness and toxicity for theranostics. This research builds on our very popular commercial products supporting theranostic treatment decision making.

09/22/2023

The Society of Nuclear Medicine and Molecular Imaging Therapeutics Conference is off to a great start! Stop by Booth 30 to talk with Dr. Weisman and Clover Ye from AIQ.

09/21/2023

AIQ is at the Society of Nuclear Medicine and Molecular Imaging Fall Therapeutics Conference today through this weekend. We will be at Exhibit 30 - stop by to say hi!

09/19/2023

AIQ Solutions is working to raise awareness about Lymphoma, a group of blood cancers in the lymphatic system. The American Cancer Society estimates 89,000 people in the U.S. will be diagnosed with lymphoma in 2023. For patients with lymphoma, oncologists use technology developed by AIQ Solutions to make more confident treatment decisions, personalize care for patients, and improve treatment outcomes.

09/15/2023

The Society of Nuclear Medicine and Molecular Imaging Fall Therapeutics Conference in Baltimore, MD is almost here. We look forward to meeting with you to discuss our solutions. Reach out today to schedule a meeting at https://www.aiq-solutions.com/contact/

Address

8000 Excelsior Drive Suite 400
Madison, WI
53717

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

http://www.aiq-solutions.com/

Alerts

Be the first to know and let us send you an email when AIQ Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to AIQ Solutions:

Shortcuts

Want your practice to be the top-listed Clinic in Madison?

WE ARE AIQ SOLUTIONS

At AIQ Solutions, we develop artificial intelligence technology to address three problems in cancer treatment: tumor heterogeneity, treatment resistance, and tumor evolution. Our patented technology platform automatically detects cancerous lesions and quantifies disease progression over time to help clinicians and researchers better understand treatment response.